ID

34303

Description

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD); ODM derived from: https://clinicaltrials.gov/show/NCT01295710

Link

https://clinicaltrials.gov/show/NCT01295710

Keywords

Versions (1)
  1. 1/16/19 1/16/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility GVHD NCT01295710

English

Eligibility GVHD NCT01295710

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Criteria
Description

Criteria

patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
Description

ID.1

Data type

boolean

patients with an unrelated hla-a,-b, -c and -drbi matched donor
Description

ID.2

Data type

boolean

patients with a karnofsky performance score ≥ 70%
Description

ID.3

Data type

boolean

key exclusion criteria:
Description

ID.4

Data type

boolean

clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
Description

ID.5

Data type

boolean

bacterial, viral, or fungal infections
Description

ID.6

Data type

boolean

known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
Description

ID.7

Data type

boolean

patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
Description

ID.8

Data type

boolean

known contraindications to the administration of rabbit immunoglobulin antibodies
Description

ID.9

Data type

boolean

hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
Description

ID.10

Data type

boolean

Back to the top of the page

Similar models

Eligibility GVHD NCT01295710

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
ID.1
Item
patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
boolean
ID.2
Item
patients with an unrelated hla-a,-b, -c and -drbi matched donor
boolean
ID.3
Item
patients with a karnofsky performance score ≥ 70%
boolean
ID.4
Item
key exclusion criteria:
boolean
ID.5
Item
clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
boolean
ID.6
Item
bacterial, viral, or fungal infections
boolean
ID.7
Item
known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
boolean
ID.8
Item
patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
boolean
ID.9
Item
known contraindications to the administration of rabbit immunoglobulin antibodies
boolean
ID.10
Item
hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
boolean
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial